Reversal of statin-induced memory dysfunction by co-enzyme Q10: a case report

被引:1
|
作者
Okeahialam, Basil N. [1 ]
机构
[1] Jos Univ Teaching Hosp, Dept Med, Cardiol Sub Unit 1, Jos, Nigeria
关键词
statin; memory dysfunction; co-enzyme Q10; improvement;
D O I
10.2147/VHRM.S90551
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Statins are useful in the armamentarium of the clinician dealing with dyslipidemia, which increases cardiovascular morbi-mortality in hypertensive and diabetic patients among others. Dyslipidemia commonly exists as a comorbidity factor in the development of atherosclerotic cardiovascular disease. Use of statins is however associated with side effects which at times are so disabling as to interfere with activities of daily living. There are various ways of dealing with this, including use of more water-soluble varieties, intermittent dosing, or use of statin alternatives. Of late, use of co-enzyme Q10 has become acceptable for the muscle side effects. Only one report of any benefit on the rarely reported memory side effect was encountered by the author in the search of English medical literature. This is a report of a documented case of a Nigerian woman with history of statin intolerance in this case, memory dysfunction despite persisting dyslipidemia comorbidity. Her memory dysfunction side effect which interfered with activities of daily living and background muscle pain cleared when coenzyme Q10 was administered alongside low dose statin. Her lipid profile normalized and has remained normal. It is being recommended for use when statin side effects (muscle-and memory-related) impair quality of life and leave patient at dyslipidemia-induced cardiovascular morbi-mortality.
引用
收藏
页码:579 / 581
页数:3
相关论文
共 50 条
  • [1] Coenzyme Q10 and Statin-Induced Mitochondrial Dysfunction
    Deichmann, Richard
    Lavie, Carl
    Andrews, Samuel
    OCHSNER JOURNAL, 2010, 10 (01): : 16 - 21
  • [2] Statin cardiomyopathy?: A potential role for co-enzyme Q10 therapy for statin-induced changes in diastolic LV performance:: Description of a clinical protocol
    Silver, MA
    Langsjoen, PH
    Szabo, S
    Patil, H
    Zelinger, A
    BIOFACTORS, 2003, 18 (1-4) : 125 - 127
  • [3] AN EFFICIENT STEREOSELECTIVE SYNTHESIS OF CO-ENZYME Q10
    SATO, K
    MIYAMOTO, O
    INOUE, S
    YAMAMOTO, T
    HIRASAWA, Y
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1982, (03) : 153 - 154
  • [4] Primary co-enzyme Q10 deficiency in an adult
    Schaefer, J.
    Weinhold, M.
    Navas, P.
    Geiger, K.
    Reichmann, H.
    Jackson, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 253 - 254
  • [5] PROTECTION OF ISCHEMIC MYOCARDIUM WITH CO-ENZYME Q10
    NAKAMURA, Y
    TAKAHASHI, M
    HAYASHI, J
    MORI, H
    OGAWA, S
    TANABE, Y
    HARA, K
    CARDIOVASCULAR RESEARCH, 1982, 16 (03) : 132 - 137
  • [6] In reply-Coenzyme Q10 and Statin-Induced Myopathy
    Banach, Maciej
    Mikhailidis, Dimitri P.
    MAYO CLINIC PROCEEDINGS, 2015, 90 (03) : 420 - 421
  • [7] Coenzyme Q10 and Statin-Induced Myopathy-II
    Braillon, Alain
    MAYO CLINIC PROCEEDINGS, 2015, 90 (03) : 420 - 420
  • [8] Coenzyme Q10 and Statin-Induced Myopathy-I
    Keller, David L.
    MAYO CLINIC PROCEEDINGS, 2015, 90 (03) : 419 - 420
  • [9] Coenzyme Q10: A therapy for hypertension and statin-induced myalgia?
    Wyman, Marcia
    Leonard, Mandy
    Morledge, Thomas
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2010, 77 (07) : 435 - 442
  • [10] Statins, cholesterol, Co-enzyme Q10, and Parkinson disease
    Lieberman, A
    Lyons, K
    Levine, J
    Myerburg, R
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (02) : 81 - 84